Atraverda plays key role in Stoney Creek Water's new...

Atraverda plays key role in Stoney Creek Water's new production line for bottled water Atraverda Ltd, a company in The Generics Group's investment portfolio, and Environmental Systems International Ltd (ESIL) announce the successful start-up of the Stoney Creek Water Company's new production line for bottled table water in Hamilton, Ontario, Canada. The water purification and sterilisation system utilises ESIL's proprietary electrolytic system, for which Atraverda provides anodes manufactured from the remarkable Ebonex conductive ceramic material. The ESIL process with Ebonex anodes produces water that greatly exceeds the normal standards for bottled water, and is probably the most benign and healthy drinking water commercially available. Brian Cook, President of ESIL, said "This is the first commercial plant using the ESIL technology, but we expect it to be the first of many world-wide in applications of bottled water production. The Ebonex anodes provided by Atraverda are a key component of the success of the ESIL technology which can also be applied to municipal water sterilisation and purification and in effluent treatment." Andrew Hill, Managing Director of Atraverda, said, "We are pleased to be associated with the ESIL technology, which we believe offers much not only to commercial bottled water companies but to resolving water supply issues in municipal, domestic, humanitarian and industrial contexts around the world." Notes for Editors: The Generics Group The Generics Group (Generics) is a leading integrated technology consulting, development and investment organisation, with an international reputation for successfully commercialising emerging science and technology. Generics invests in and develops technologies that underpin the future of the widest range of industries. Generics' facilities include state-of- the-art laboratories and are located in Cambridge, UK; in Zürich, Switzerland; in Stockholm, Sweden; and in Boston and Baltimore in the USA. Generics has over 300 employees, of which more than half are high- calibre technology professionals. ATRAVERDA Atraverda is one of thirty-seven companies in an investment portfolio held by The Generics Group. Atraverda's battery, water and effluent treatment, and corrosion prevention technology is based on patented conducting ceramic materials (known as Ebonex materials) and is capable of increasing substantially the performance of lead acid batteries in most applications including the automotive industry. Contacts: For Generics: Ruth Shaw, PR Manager, rshaw@genericsgroup.com Tel: +44 (0) 1223 875200 Web: www.genericsgroup.com For Atraverda: Andrew Hill, Managing Director, +44-07000-EBONEX, ahill@atraverda.com, http://atraverda.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/04/15/20020415BIT00760/wkr0001.doc http://www.waymaker.net/bitonline/2002/04/15/20020415BIT00760/wkr0002.pdf